The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older individuals worldwide. The disease is characterized by abnormal extracellular deposits, known as drusen, that accumulate along the basal surface of the retinal pigmented epithelium. Although drusen deposition is common in older individuals, large numbers of drusen and/or extensive areas of confluent drusen represent a significant risk factor for AMD. Widespread drusen deposition is associated with retinal pigmented epithelial cell dysfunction and degeneration of the photoreceptor cells of the neural retina. Recent studies have shown that drusen contain a variety of immunomodulatory molecules, suggesting that the process of drusen formation involves local inflammatory events, including activation of the complement cascade. Similar observations in Alzheimer's disease (AD) have lead to the hypothesis that chronic localized inflammation is an important element of AD pathogenesis, with significant neurodegenerative consequences. Accordingly, the amyloid beta (Aβ) peptide, a major constituent of neuritic plaques in AD, has been implicated as a primary activator of complement in AD. Here we show that Aβ is associated with a substructural vesicular component within drusen. Aβ colocalizes with activated complement components in these “amyloid vesicles,” thereby identifying them as potential primary sites of complement activation. Thus, Aβ deposition could be an important component of the local inflammatory events that contribute to atrophy of the retinal pigmented epithelium, drusen biogenesis, and the pathogenesis of AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Complement components, other inflammatory molecules, lipids, lipoproteins B and E, and glycoproteins are common constituents of ocular drusen (Johnson et al., 2002).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Johnson et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Bustin, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,872
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citationMullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Self-citationNormal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Self-citationAccumulation of cholesterol with age in human Bruch's membrane.
Curcio, C. A., Millican, C. L., Bailey, T. A., & Kruth, H. S. (2001) · PubMed · Cited by 508
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Golde, T. E., Estus, S., Usiak, M., Younkin, L. H., & Younkin, S. G. (1990) · Neuron · doi:10.1016/0896-6273(90)90100-t · Cited by 432
Transthyretin sequesters amyloid beta protein and prevents amyloid formation.
Schwarzman, A. L., Gregori, L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., Bhasin, R., Silverman, J., Weisgraber, K. H., & Coyle, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8368 · Cited by 413
Basal Linear Deposit and Large Drusen Are Specific for Early Age-Related Maculopathy
Curcio, C. A. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.3.329 · Cited by 386
A potential role for immune complex pathogenesis in drusen formation
JOHNSON, L. V., OZAKI, S., STAPLES, M. K., ERICKSON, P. A., & ANDERSON, D. H. (2000) · Experimental Eye Research · doi:10.1006/exer.1999.0798 · Cited by 353
Self-citationEvans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H., & Lansbury, P. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.763 · Cited by 333
Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR.
Simpson, D. A. C., Feeney, S. A., Boyle, C., & Stitt, A. W. (2000) · PubMed · Cited by 326
Webster, S., Lue, L.-F., Brachova, L., Tenner, A. J., McGeer, P. L., Terai, K., Walker, D. G., Bradt, B., Cooper, N. R., & Rogers, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00042-0 · Cited by 258
Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide
Bradt, B. M., Kolb, W. P., & Cooper, N. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.431 · Cited by 255
Anderson, D. H., Ozaki, S., Nealon, M., Neitz, J., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00961-2 · Cited by 255
Self-citationBRESSLER, N. M., SILVA, J. C., BRESSLER, S. B., FINE, S. L., & GREEN, W. R. (2005) · Retina · doi:10.1097/00006982-200507001-00016 · Cited by 224
Regulation of the Complement Membrane Attack Pathway
Morgan, B. P. (1999) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v19.i3.10 · Cited by 222
Hageman, G. S., Mullins, R. F., Russell, S. R., Johnson, L. V., & Anderson, D. H. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.3.477 · Cited by 206
Self-citationBRESSLER, N. M., SILVA, J. C., BRESSLER, S. B., FINE, S. L., & GREEN, W. R. (1994) · Retina · doi:10.1097/00006982-199414020-00006 · Cited by 200
Intracellular APP Processing and Aβ Production in Alzheimer Disease
Wilson, C. A., Doms, R. W., & Lee, V. M.-Y. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199908000-00001 · Cited by 187
Russell, S. R., Mullins, R. F., Schneider, B. L., & Hageman, G. S. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00345-1 · Cited by 170
Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina.
Löffler, K. U., Edward, D. P., & Tso, M. O. M. (1995) · PubMed · Cited by 169
Is Age-related Maculopathy Associated with Alzheimer's Disease?: The Rotterdam Study
Klaver, C. C. W., Ott, A., Hofman, A., Assink, J. J. M., Breteler, M. M. B., & de Jong, P. T. V. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010105 · Cited by 162
Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction
Matsubara, E., Frangione, B., & Ghiso, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7563 · Cited by 153
Hilbich, C., Mönning, U., Grund, C., Masters, C. L., & Beyreuther, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74350-6 · Cited by 137
Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation.
Eriksson, S., Janciauskiene, S. M., & Lannfelt, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2313 · Cited by 137
Clinico-morphologic correlations of drusen of Bruch's membrane.
Burns, R. P., & Feeney-Burns, L. (1980) · PubMed Central · Cited by 136
Complement regulatory proteins in glomerular diseases
Nangaku, M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00130.x · Cited by 133
Formation of Drusen in the Human Eye
Ishibashi, T., Patterson, R., Ohnishi, Y., Inomata, H., & Ryan, S. J. (1986) · American Journal of Ophthalmology · doi:10.1016/0002-9394(86)90830-5 · Cited by 117
Processes in atherogenesis: complement activation
Torzewski, J. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00100-7 · Cited by 111
DRUSEN PATTERNS PREDISPOSING TO GEOGRAPHIC ATROPHY OF THE RETINAL PIGMENT EPITHELIUM
Sarks, S. H. (1982) · Australian Journal of Opthalmology · doi:10.1111/j.1442-9071.1982.tb00366.x · Cited by 83
Lin, H., & Clegg, D. (1998) · PubMed · Cited by 77
Anderson, D. H., Johnson, L. V., & Hageman, G. S. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903600102 · Cited by 65
Self-citationWestlind‐Danielsson, A., & Arnerup, G. (2001) · Biochemistry · doi:10.1021/bi010375c · Cited by 63
Terai, K., Iwai, A., Kawabata, S., Tasaki, Y., Watanabe, T., Miyata, K., & Yamaguchi, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00095-1 · Cited by 59
Amyloid P Component Promotes Aggregation of Alzheimer′s β-Amyloid Peptide
Hamazaki, H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1819 · Cited by 50
Beckman, M., & Iverfeldt, K. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13292-4 · Cited by 48
Human retinal pigment cell culture
Aronson, J. F. (1983) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02619578 · Cited by 46
The Human Retina and Retinal Pigment Epithelium Are Abundant Sources of Vitronectin mRNA
Ozaki, S., Johnson, L. V., Mullins, R. F., Hageman, G. S., & Anderson, D. H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0672 · Cited by 33
Self-citationScanning electron microscopy of human drusen.
Ulshafer, R. J., Allen, C. B., Nicolaissen, B., & Rubin, M. L. (1987) · PubMed · Cited by 30
Research works printed but not linked: 9
- G S Hageman, P J Luthert, N H V Chong, L V Johnson, D H Anderson, R F Mullins Progr. Ret. Eye Res., eds N N Osborne, G J Chader (Elsevier Science, London) 20, 705–732 (2001).
- H Lin, D O Clegg Invest Ophthalmol Visual Sci 39, 1703–1712 (1998).
- K S Kim, D L Miller, V J Sapienza, C M J Chen, C Bai, I Grundke-Iqbal, J R Currie, H M Wisniewski Neurosci Res Comm 2, 121–130 (1988).
- K S Kim, G Y Wen, C Bancher, C M J Chen, V J Sapienza, H Hong, H M Wisniewski Neurosci Res Commun 7, 113–122 (1990).
- D A Simpson, S Feeney, C Boyle, A W Stitt Mol Vis 6, 178–183 (2000).
- C A Curcio, C L Millican, T Bailey, H S Kruth Invest Ophthalmol Visual Sci 42, 265–274 (2001).
- K Loeffler, D Edward, M Tso Invest Ophthalmol Visual Sci 36, 24–31 (1995).
- R P Burns, L Feeney-Burns Trans Am Ophthalmol Soc 78, 206–225 (1980).
- R J Ulshafer, C B Allen, B Nicolaissen, M L Rubin Invest Ophthalmol Visual Sci 28, 683–689 (1987).
Cited by
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationThe retina as a window to the brain—from eye research to CNS disorders
London, A., Benhar, I., & Schwartz, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.227 · Cited by 1,403
Current concepts in the pathogenesis of age-related macular degeneration
Zarbin, M. A. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.598 · Cited by 1,006
Anderson, D. H., Radeke, M. J., Gallo, N. B., Chapin, E. A., Johnson, P. T., Curletti, C. R., Hancox, L. S., Hu, J., Ebright, J. N., Malek, G., et al. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.11.003 · Cited by 727
Self-citationDrusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650
Metadata
- Authors
- Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H.
- Affiliations
- University of California, Santa Barbara (US)
- Johns Hopkins University (US)
- ORCID
- Radeke, Monte J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-20
- Volume
- 99
- Issue
- 18
- Pages
- 11830-11835
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC129354
- OpenAlex
- W2003101845
- Cited by
- 447
- References
- 45
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 14 · 2023: 8 · 2022: 17 · 2021: 20 · 2020: 20 · 2019: 14 · 2018: 19 · 2017: 26 · 2016: 24 · 2015: 34 · 2014: 38 · 2013: 21 · 2012: 23
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY011521, EY 11-521, R01EY011527, EY11527)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- amyloid-beta, complement activation, age-related macular degeneration, drusen, retinal pigment epithelium, neuroinflammation, retinal aging, neuritic plaques, complement proteins
- MeSH terms
- Aged, Aged, 80 and over, Aging, Base Sequence, Complement Activation, Humans, Immunohistochemistry, Macular Degeneration, Middle Aged, Polymerase Chain Reaction, Amyloid beta-Peptides, DNA Primers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.